Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Novamab Biopharmaceuticals Co., Ltd.

Clinical trials sponsored by Shanghai Novamab Biopharmaceuticals Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New inhaled antibody could help asthma sufferers breathe easier Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New inhaled antibody could help asthma sufferers breathe easier

Disease control Recruiting now

This study tests whether an inhaled drug called LQ036 can improve lung function and asthma control in people whose asthma is not well managed with current treatments. About 216 participants will inhale the drug or a placebo once daily for 24 weeks. The main goal is to see if LQ03…

Phase 2 • Sponsor: Shanghai Novamab Biopharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC